USD10
AXSM Shares
About Axsome TherapeuticsAxsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

USD10
AXSM Shares
About Axsome TherapeuticsAxsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Stats

TRADING WINDOW

Closed

OPENS AT

Jul 14 at 1:30 PM GMT+0

MARKET CAP

$11.75B

OPEN PRICE

Not enough data

LOW (1Y)

$96.09

HIGH (1Y)

$260.19

LOW (24H)

$224.70

HIGH (24H)

$231.81

VOLUME (24H)

$435.51K

43,551,316.43%

Price history

Time
Price
Change
Today
Not enough data
Not enough data
1 Day
$230.02
0.76%
1 Week
$243.71
6.33%
1 Month
$261.90
12.84%
1 Year
$110.12
107.30%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.